Synthetic Biology Market

Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration, Biofuel, Renewable Energy, Food & Agriculture, Bioremediation) - Global Forecast to 2025

Report Code: BT 2910 Feb, 2020, by marketsandmarkets.com
COVID-19

Get in-depth analysis of how COVID-19 is impacting the Synthetic Biology Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Synthetic Biology Market

Request Now

[256 Pages Report] The synthetic biology market is projected to reach USD 19.8 billion by 2025 from USD 6.8 billion in 2020, at a CAGR of 23.9%. The growth of this market is primarily attributed to factors such as the increasing demand for synthetic genes & synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing & synthesizing, increasing R&D funding & initiatives in synthetic biology, and increasing investments in the market.

Synthetic Biology Market - Attractive Opportunities by 2022

By tool, oligonucleotides and synthetic DNA dominated the synthetic biology market in 2019.

Based on tools, the market segmented into oligonucleotides and synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms and xeno-nucleic acid. In 2019, the oligonucleotides and synthetic DNA segment accounted for the largest share of the market, followed by enzymes. The large share of the segment can be attributed to the rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of research applications.

Gene synthesis accounted for the largest share of the synthetic biology market in 2019.

Based on technology, the market is segmented into gene synthesis, genome engineering, cloning, sequencing, site-directed mutagenesis, measurement & modeling, microfluidics, nanotechnology, and bioinformatics technologies. In 2019, the gene synthesis segment accounted for the largest share of the market. This large share of the segment can be attributed to the rising demand for synthetic DNA, synthetic RNA, and oligonucleotides across various application industries and its increasing use with genome engineering for the ease and efficiency in genome editing and genome targeting.

Medical applications formed the largest segment of the synthetic biology market in 2019

Based on application, the market is segmented into environmental, medical, industrial, and food & agricultural applications. In 2019, the medical applications segment accounted for the largest share of the market, followed by industrial applications. The extensive research on new and better treatments, coupled with the availability of huge private and public funding for the discovery of novel therapies, is the primary driver for the medical applications segment.

Synthetic Biology Market - Attractive Opportunities by 2022

The APAC market is expected to grow at the highest CAGR during the forecast period

The market in the Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as growth in the number of pharmaceutical & biopharmaceutical companies, the increasing number of healthcare & life science facilities, and increasing requirements for regulatory compliance in pharmaceutical and biopharmaceutical companies, growing number of international alliances, heavy funding for synthetic biology research, and strong government support are expected to drive the growth of these markets during the forecast period. Furthermore, the increasing focus on the Asia Pacific markets due to their low-cost manufacturing advantage also provides growth opportunities for manufacturers.

Key Market Players

The prominent players in the synthetic biology market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris, Inc. (US), Intrexon Corporation (US), GenScript Biotech Corporation (China), Twist Bioscience (US), Synthetic Genomics, Inc. (US), Codexis, Inc. (US), Synthego Corporation (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg), Cyrus Biotechnology Inc. (US), ATUM (US), TeselaGen (US), Arzeda (US), Integrated DNA Technologies, Inc. (US), and New England Biolabs (US).

The global market was dominated by Thermo Fisher Scientific, Inc. (US) in 2019. The company offers synthetic biology products, which include DNA fragments, software, engineering kits, DNA oligos, and clones. The company‘s large share in this market can be attributed to its broad product portfolio, years of experience, and vast distribution channel. The company’s distribution network comprises a broad sales force and a global network of resellers and distributors. Thermo is equipped with an international network of warehouses, specialized product vaults, and warehouse management systems that maintain the inventory and coordinate product deliveries. Throughout the product delivery process, the company provides its customers with convenient access to comprehensive electronic systems, allowing for automated catalog search, product orders, and invoicing & payment capabilities.

Scope of the Report:

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Currency

USD (Value)

Segments covered

By Tool, Technology, Application, Region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

Companies covered

Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris, Inc. (US), Intrexon Corporation (US), GenScript Biotech Corporation (China), Twist Bioscience (US), Synthetic Genomics, Inc. (US), Codexis, Inc. (US), Synthego Corporation (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg), Cyrus Biotechnology Inc. (US), ATUM (US), TeselaGen (US), Arzeda (US), Integrated DNA Technologies, Inc. (US), and New England Biolabs (US)

The research report categorizes the market into the following segments and subsegments:

Synthetic Biology Market, by Tool

  • Oligonucleotides and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Synthetic Cells
  • Chassis Organisms
  • Xeno-nucleic Acids

Synthetic Biology Market, by Technology

  • Gene Synthesis
  • Genome Engineering
  • Cloning
  • Sequencing
  • Site-directed Mutagenesis
  • Measurement and Modeling
  • Microfluidics
  • Nanotechnology
  • Bioinformatics

Synthetic Biology Market, Application

  • Medical Application
  • Pharmaceuticals
  • Drug Discovery and Therapeutics
      • Cancer Detection & Diagnostics
      • Other Drug Discovery and Therapeutic Applications
  • Artificial Tissue and Tissue Regeneration
      • Bio-synthesis
      • Stem Cell Regulation
      • Other Tissue and Tissue Regeneration Applications
  • Industrial Applications
  • Biofuel and Renewable Energy
  • Biomaterials and Green Chemicals
  • Industrial Enzymes, by Application
      • Textile Industry
      • Paper Industry
      • Other Industries
  • Food & Agriculture
  • Environmental Applications
  • Bioremediation
  • Biosensing

Synthetic Biology Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Denmark
    • Switzerland
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • In December 2019, Amyris, Inc. (US) launched the PURECANE Brand Sweetener.
  • In December 2019, Cyrus Biotechnology Inc. (US) collaborated with the Broad Institute of MIT and Harvard to develop an optimized CRISPR gene-editing technology. This helped Cyrus to gain further commercial access for its Rosetta technology.
  • In August 2019, Agilent Technologies, Inc. (US) acquired BioTek Instruments (US), a manufacturer of life science instrumentation, thereby expanding Agilent’s growing presence and expertise in cell analysis and also strengthening the company’s position in the large and growing immuno-oncology and immunotherapy areas.
  • In June 2019, Novozymes A/S (Denmark) opened its Innovation Campus in Lyngby, Denmark, for research in biological solutions.
  • In April 2019, Precigen, Inc., a wholly-owned subsidiary of Intrexon Corporation (US), opened a new manufacturing facility in Germantown, Maryland, for supporting the gene therapy manufacturing.

Critical questions answered in the report:

  • How will current technological trends affect the market in the long-term?
  • What are the current growth trends in the market for the food & agriculture segment?
  • What are the application areas of the market?
  • Which regions are likely to grow at the highest CAGR?
  • What are the growth strategies being implemented by major market players?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 24)
    1.1 Objectives of the Study
    1.2 Market Definition & Scope
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Stakeholders
    1.5 Limitations

2 Research Methodology (Page No. - 27)
    2.1 Research Approach
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Market Size Estimation
    2.3 Data Triangulation Approach
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 35)

4 Premium Insights (Page No. - 39)
    4.1 Market Overview
    4.2 Asia Pacific: Market, By Application
    4.3 Market: Geographic Growth Opportunities
    4.4 Market, By Region (2018–2025)
    4.5 Market: Developed vs. Developing Markets

5 Market Overview (Page No. - 43)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Wide Range of Applications of Synthetic Biology
                    5.2.1.2 Rising R&D Funding and Growing Initiatives in Synthetic Biology
                    5.2.1.3 Declining Cost of Dna Sequencing and Synthesizing
                    5.2.1.4 Increasing Investments in the Market
           5.2.2 Restraints
                    5.2.2.1 Biosafety, Biosecurity, and Ethical Concerns
           5.2.3 Opportunities
                    5.2.3.1 Rising Need for Fuel Alternatives
                    5.2.3.2 Increasing Demand for Protein Therapeutics and Personalized Medicine
                    5.2.3.3 Increasing Research in Synthetic Drugs and Vaccines
           5.2.4 Challenges
                    5.2.4.1 Standardization of Biological Parts

6 Synthetic Biology Market, By Tool (Page No. - 52)
    6.1 Introduction
    6.2 Oligonucleotides & Synthetic Dna
           6.2.1 Oligonucleotides and Synthetic Dna to Dominate the Market During the Forecast Period
    6.3 Enzymes
           6.3.1 Development of Enzymes has Helped in Evolving New Therapies for A Range of Diseases
    6.4 Cloning Technology Kits
           6.4.1 Need for the Creation of Artificial Dna Along With Their Assembly is Driving the Growth of the Segment
    6.5 Synthetic Cells
           6.5.1 Synthetic Cells Will Allow Tailoring Biologics and Its Adoption is Expected to Grow in the Coming Years
    6.6 Chassis Organisms
           6.6.1 Increasing Demand for Fossil Fuels is Likely to Propel the Demand for Chassis Organisms
    6.7 Xeno-Nucleic Acids
           6.7.1 Xnas are Increasingly Researched With the Growing Demand for Breakthrough Medicine

7 Synthetic Biology Market, By Technology (Page No. - 63)
    7.1 Introduction
    7.2 Gene Synthesis
           7.2.1 Gene Synthesis to Dominate the Market During the Forecast Period
    7.3 Genome Engineering
           7.3.1 Increasing Demand for Synthetic Dna and Genes is Expected to Drive Market Growth
    7.4 Sequencing
           7.4.1 Ngs Technology is Rapidly Becoming an Indispensable and Universal Tool for Biological Research
    7.5 Bioinformatics
           7.5.1 Use of Bioinformatics Technologies is Increasing With the Rising Need for Data Management and Curation
    7.6 Cloning
           7.6.1 Cloning Aids in Building New Genetic Modules/Pathways, Enabling Rapid Advances in Research Across Various Industries
    7.7 Site-Directed Mutagenesis
           7.7.1 Wide Applications in Genetic Engineering, Dna Assembly, and Cloning Technologies is Driving This Segment
    7.8 Measurement & Modeling
           7.8.1 Computational Modeling is Aiding the Growth of the Segment During the Forecast Period
    7.9 Microfluidics
           7.9.1 Droplet Microfluidics is Gaining Wide Recognition in the Field of Synthetic Biology
    7.1 Nanotechnology
    7.10.1 Convergence Between Synthetic Biology and Nanotechnologies Aid in Building Complex Bodies

8 Synthetic Biology Market, By Application (Page No. - 79)
    8.1 Introduction
    8.2 Medical Applications
           8.2.1 Pharmaceuticals
                    8.2.1.1 In 2019, the Pharmaceuticals Segment Accounted for the Largest Share of the Medical Applications Market
           8.2.2 Drug Discovery and Therapeutics
                    8.2.2.1 Cancer Detection & Diagnostics
                               8.2.2.1.1 With Rising Investments for Cancer Research, the Market for Synthetic Biology is Expected to Grow for This Segment
                    8.2.2.2 Other Drug Discovery and Therapeutic Applications
           8.2.3 Artificial Tissue & Tissue Regeneration
                    8.2.3.1 Bio-Synthesis
                               8.2.3.1.1 Bio-Synthesis is Dominating the Market With Its Increasing Adoption in Creating Artificial Genomes
                    8.2.3.2 Stem Cell Regulation
                               8.2.3.2.1 Use of Synthetic Biology in Stem Cell Regeneration and Reprogramming Somatic Cells is Expected to Drive Market Growth
                    8.2.3.3 Other Artificial Tissue and Tissue Regeneration Applications
    8.3 Industrial Applications
           8.3.1 Biofuel and Renewable Energy
                    8.3.1.1 Advantages of Using Genetically Engineered Organisms for the Synthetic Production of Biofuels is Driving Market Growth
           8.3.2 Industrial Enzymes
                    8.3.2.1 Textile Industry
                               8.3.2.1.1 Synthetic Biology is Being Applied in the Textile Industry to Replace Traditional Raw Materials
                    8.3.2.2 Paper Industry
                               8.3.2.2.1 Enzymes are Being Increasingly Used in the Pulp and Paper Industry
                    8.3.2.3 Other Industries
           8.3.3 Biomaterials & Green Chemicals
                    8.3.3.1 Silk-Based Proteins are A Type of Biomaterial Prepared Through Synthetic Biology
    8.4 Food & Agriculture
           8.4.1 Synthetic Biology Techniques are Applied in the Food and Agriculture Industry to Produce Metabolites, Health Products, and Processing Aids
    8.5 Environmental Applications
           8.5.1 Bioremediation
                    8.5.1.1 Owing to the Growing Severity of Environmental Problems, It has Become Necessary to Develop Cost-Effective, On-Site Methods for Environmental Monitoring and Bioremediation
           8.5.2 Biosensing
                    8.5.2.1 Biosensor Applications Commonly Make Use of Microalgae Owing to Their High Reproductive Rates and Ease of Culturing Due to Their Microscopic Size

9 Synthetic Biology Market, By Region (Page No. - 108)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 The US Dominates the North American Market
           9.2.2 Canada
                    9.2.2.1 Strong Research Infrastructure and Availability of Funding Will Support Market Growth
    9.3 Europe
           9.3.1 UK
                    9.3.1.1 The UK Holds the Largest Share of the European Market
           9.3.2 Germany
                    9.3.2.1 The Rapidly Growing Pharmaceutical Market is Expected to Drive Market Growth
           9.3.3 France
                    9.3.3.1 Research Across All Industries is Strongly Supported By the Government
           9.3.4 Denmark
                    9.3.4.1 Denmark has the Third-Largest Commercial Drug-Development Pipeline in Europe
           9.3.5 Switzerland
                    9.3.5.1 Market Growth is Primarily Driven By the Well-Established Pharmaceutical & Biotechnology Industry in the Country
           9.3.6 Spain
                    9.3.6.1 Spain has A Well-Established Network of Research Centers, Universities, and Hospitals, Which Form an Ideal Environment for Research
           9.3.7 Italy
                    9.3.7.1 Growth in This Market is Mainly Driven By Increasing Life Science R&D in the Country, Funded By Both Public and Private Organizations
           9.3.8 Rest of Europe
    9.4 Asia Pacific
           9.4.1 Japan
                    9.4.1.1 Large Number of Research Initiatives Towards the Development of Precision Medicine Supporting Market Growth
           9.4.2 China
                    9.4.2.1 Growth in R&D to Enhance the Technological Capabilities in the Country, Thereby Driving the Demand for High-Quality Research Tools
           9.4.3 Australia
                    9.4.3.1 Increasing Focus of the Healthcare System on Precision Medicine to Offer Significant Growth Opportunities
           9.4.4 India
                    9.4.4.1 Increasing Pharma R&D and Government Funding in the Biotechnology Industry are the Major Factors Driving Market Growth
           9.4.5 Rest of Asia Pacific
    9.5 Latin America
           9.5.1 Strong Pharmaceutical Industry in the Region to Provide Significant Growth Opportunities
    9.6 Middle East and Africa
           9.6.1 Increasing Partnerships Among Global Players With Government Organizations in the Region to Support Growth

10 Competitive Landscape (Page No. - 198)
     10.1 Overview
     10.2 Market Share Analysis
             10.2.1 Synthetic Biology Market, By Key Players, 2018
     10.3 Competitive Leadership Mapping
             10.3.1 Visionary Leaders
             10.3.2 Innovators
             10.3.3 Dynamic Differentiators
             10.3.4 Emerging Companies
     10.4 Competitive Situation and Trends
             10.4.1 Product Launches
             10.4.2 Expansions
             10.4.3 Acquisitions
             10.4.4 Other Strategies

11 Company Profiles (Page No. - 205)
     11.1 Thermo Fisher Scientific, Inc.
             11.1.1 Business Overview
             11.1.2 Products Offered
             11.1.3 Recent Developments
             11.1.4 MnM View
     11.2 Merck Kgaa
             11.2.1 Business Overview
             11.2.2 Products Offered
             11.2.3 Recent Developments
             11.2.4 MnM View
     11.3 Agilent Technologies, Inc.
             11.3.1 Business Overview
             11.3.2 Products & Services Offered
             11.3.3 Recent Developments
             11.3.4 MnM View
     11.4 Novozymes A/S
             11.4.1 Business Overview
             11.4.2 Products Offered
             11.4.3 Recent Developments
             11.4.4 MnM View
     11.5 Ginkgo Bioworks
             11.5.1 Business Overview
             11.5.2 Products Offered
             11.5.3 Recent Developments
     11.6 Amyris, Inc.
             11.6.1 Business Overview
             11.6.2 Products Offered
             11.6.3 Recent Developments
     11.7 Intrexon Corporation
             11.7.1 Business Overview
             11.7.2 Products Offered
             11.7.3 Recent Developments
     11.8 Genscript Biotech Corporation
             11.8.1 Business Overview
             11.8.2 Products & Services Offered
             11.8.3 Recent Developments
     11.9 Twist Bioscience
             11.9.1 Business Overview
             11.9.2 Products Offered
             11.9.3 Recent Developments
     11.10 Synthetic Genomics, Inc. (SGI)
             11.10.1 Business Overview
             11.10.2 Products Offered
             11.10.3 Recent Developments
     11.11 Codexis, Inc.
             11.11.1 Business Overview
             11.11.2 Products Offered
             11.11.3 Recent Developments
     11.12 Synthego Corporation
             11.12.1 Business Overview
             11.12.2 Products Offered
             11.12.3 Recent Developments
     11.13 Creative Enzymes
             11.13.1 Business Overview
             11.13.2 Products & Services Offered
             11.13.3 Recent Developments
     11.14 Eurofins Scientific
             11.14.1 Business Overview
             11.14.2 Services Offered
             11.14.3 Recent Developments
     11.15 Cyrus Biotechnology, Inc.
             11.15.1 Business Overview
             11.15.2 Products & Services Offered
             11.15.3 Recent Developments
     11.16 Other Major Companies
             11.16.1 Atum
             11.16.2 Teselagen
             11.16.3 Arzeda
             11.16.4 Integrated Dna Technologies, Inc.
             11.16.5 New England Biolabs

12 Appendix (Page No. - 248)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (234 Tables)

Table 1 Synthetic Biology Market, By Tool, 2018–2025 (USD Million)
Table 2 Market for Tools, By Country/Region, 2018–2025 (USD Million)
Table 3 Market for Oligonucleotides & Synthetic Dna, By Country, 2018–2025 (USD Million)
Table 4 Market for Enzymes, By Country, 2018–2025 (USD Million)
Table 5 Market for Cloning Technology Kits, By Country, 2018–2025 (USD Million)
Table 6 Market for Synthetic Cells, By Country, 2018–2025 (USD Million)
Table 7 Market for Chassis Organisms, By Country, 2018–2025 (USD Million)
Table 8 Market for Xeno-Nucleic Acids, By Country, 2018–2025 (USD Million)
Table 9 Market, By Technology, 2018–2025 (USD Million)
Table 10 Market for Technology, By Country, 2018–2025 (USD Million)
Table 11 Market for Gene Synthesis, By Country, 2018–2025 (USD Million)
Table 12 Market for Genome Engineering, By Country, 2018–2025 (USD Million)
Table 13 Market for Sequencing, By Country, 2018–2025 (USD Million)
Table 14 Market for Bioinformatics, By Country, 2018–2025 (USD Million)
Table 15 Synthetic Biology Market for Cloning, By Country, 2018–2025 (USD Million)
Table 16 Market for Site-Directed Mutagenesis, By Country/Region, 2018–2025 (USD Million)
Table 17 Market for Measurement & Modeling, By Country, 2018–2025 (USD Million)
Table 18 Market for Microfluidics, By Country, 2018–2025 (USD Million)
Table 19 Market for Nanotechnology, By Country, 2018–2025 (USD Million)
Table 20 Market, By Application, 2018–2025 (USD Million)
Table 21 Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 22 Market for Medical Applications, By Country, 2018–2025 (USD Million)
Table 23 Market for Pharmaceuticals, By Country, 2018–2025 (USD Million)
Table 24 Market for Drug Discovery and Therapeutics, By Type, 2018–2025 (USD Million)
Table 25 Market for Drug Discovery and Therapeutics, By Country, 2018–2025 (USD Million)
Table 26 Market for Cancer Detection & Diagnostics, By Country, 2018–2025 (USD Million)
Table 27 Market for Other Drug Discovery and Therapeutic Applications, By Country, 2018–2025 (USD Million)
Table 28 Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 29 Market for Artificial Tissue & Tissue Regeneration, By Country, 2018–2025 (USD Million)
Table 30 Market for Biosynthesis, By Country, 2018–2025 (USD Million)
Table 31 Market for Stem Cell Regulation, By Country, 2018–2025 (USD Million)
Table 32 Market for Other Artificial Tissue and Tissue Regeneration Applications, By Country, 2018–2025 (USD Million)
Table 33 Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 34 Synthetic Biology Market for Industrial Applications, By Country, 2018–2025 (USD Million)
Table 35 Market for Biofuel and Renewable Energy, By Country, 2018–2025 (USD Million)
Table 36 Market for Industrial Enzymes, By Industry, 2018–2025 (USD Million)
Table 37 Market for Industrial Enzymes, By Country, 2018–2025 (USD Million)
Table 38 Market for Textile Industry, By Country, 2018–2025 (USD Million)
Table 39 Market for Paper Industry, By Country, 2018–2025 (USD Million)
Table 40 Market for Other Industries, By Country, 2018–2025 (USD Million)
Table 41 Market for Biomaterials and Green Chemicals, By Country, 2018–2025 (USD Million)
Table 42 Market for Food and Agriculture, By Country, 2018–2025 (USD Million)
Table 43 Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 44 Market for Environmental Applications, By Country, 2018–2025 (USD Million)
Table 45 Market for Bioremediation, By Country, 2018–2025 (USD Million)
Table 46 Market for Biosensing, By Country, 2018–2025 (USD Million)
Table 47 Market, By Region, 2018–2025 (USD Million)
Table 48 North America: Market, By Country, 2018–2025 (USD Million)
Table 49 North America: Market, By Tool, 2018–2025 (USD Million)
Table 50 North America: Market, By Technology, 2018–2025 (USD Million)
Table 51 North America: Market, By Application, 2018–2025 (USD Million)
Table 52 North America: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 53 North America: Synthetic Biology Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 54 North America: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 55 North America: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 56 North America: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 57 North America: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 58 US: Market, By Tool, 2018–2025 (USD Million)
Table 59 US: Market, By Technology, 2018–2025 (USD Million)
Table 60 US: Market, By Application, 2018–2025 (USD Million)
Table 61 US: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 62 US: Synthetic Biology Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 63 US: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 64 US: Market for IndUStrial Applications, By Type, 2018–2025 (USD Million)
Table 65 US: Market for IndUStrial Enzymes, By Application, 2018–2025 (USD Million)
Table 66 US: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 67 Canada: Market, By Tool, 2018–2025 (USD Million)
Table 68 Canada: Market, By Technology, 2018–2025 (USD Million)
Table 69 Canada: Market, By Application, 2018–2025 (USD Million)
Table 70 Canada: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 71 Canada: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 72 Canada: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 73 Canada: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 74 Canada: Synthetic Biology Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 75 Canada: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 76 Europe: Market, By Country, 2018–2025 (USD Million)
Table 77 Europe: Market, By Tool, 2018–2025 (USD Million)
Table 78 Europe: Market, By Technology, 2018–2025 (USD Million)
Table 79 Europe: Market, By Application, 2018–2025 (USD Million)
Table 80 Europe: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 81 Europe: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 82 Europe: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 83 Europe: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 84 Europe: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 85 Europe: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 86 UK: Market, By Tool, 2018–2025 (USD Million)
Table 87 UK: Market, By Technology, 2018–2025 (USD Million)
Table 88 UK: Market, By Application, 2018–2025 (USD Million)
Table 89 UK: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 90 UK: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 91 UK: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 92 UK: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 93 UK: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 94 UK: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 95 Germany: Synthetic Biology Market, By Tool, 2018–2025 (USD Million)
Table 96 Germany: Market, By Technology, 2018–2025 (USD Million)
Table 97 Germany: Market, By Application, 2018–2025 (USD Million)
Table 98 Germany: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 99 Germany: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 100 Germany: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 101 Germany: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 102 Germany: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 103 Germany: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 104 France: Market, By Tool, 2018–2025 (USD Million)
Table 105 France: Market, By Technology, 2018–2025 (USD Million)
Table 106 France: Market, By Application, 2018–2025 (USD Million)
Table 107 France: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 108 France: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 109 France: Synthetic Biology Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 110 France: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 111 France: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 112 France: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 113 Denmark: Market, By Tool, 2018–2025 (USD Million)
Table 114 Denmark: Market, By Technology, 2018–2025 (USD Million)
Table 115 Denmark: Market, By Application, 2018–2025 (USD Million)
Table 116 Denmark: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 117 Denmark: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 118 Denmark: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 119 Denmark: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 120 Denmark: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 121 Denmark: Synthetic Biology Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 122 Switzerland: Market, By Tool, 2018–2025 (USD Million)
Table 123 Switzerland: Market, By Technology, 2018–2025 (USD Million)
Table 124 Switzerland: Market, By Application, 2018–2025 (USD Million)
Table 125 Switzerland: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 126 Switzerland: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 127 Switzerland: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 128 Switzerland: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 129 Switzerland: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 130 Switzerland: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 131 Spain: Market, By Tool, 2018–2025 (USD Million)
Table 132 Spain: Market, By Technology, 2018–2025 (USD Million)
Table 133 Spain: Market, By Application, 2018–2025 (USD Million)
Table 134 Spain: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 135 Spain: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 136 Spain: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 137 Spain: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 138 Spain: Market for Industrial Enzymes, By Industry, 2018–2025 (USD Million)
Table 139 Spain: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 140 Italy: Market, By Tool, 2018–2025 (USD Million)
Table 141 Italy: Market, By Technology, 2018–2025 (USD Million)
Table 142 Italy: Market, By Application, 2018–2025 (USD Million)
Table 143 Italy: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 144 Italy: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 145 Italy: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 146 Italy: Synthetic Biology Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 147 Italy: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 148 Italy: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 149 RoE: Market, By Tool, 2018–2025 (USD Million)
Table 150 RoE: Market, By Technology, 2018–2025 (USD Million)
Table 151 RoE: Market, By Application, 2018–2025 (USD Million)
Table 152 RoE: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 153 RoE: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 154 RoE: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 155 RoE: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 156 RoE: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 157 RoE: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 158 Asia Pacific: Market, By Country, 2018–2025 (USD Million)
Table 159 Asia Pacific: Market, By Tool, 2018–2025 (USD Million)
Table 160 Asia Pacific: Market, By Technology, 2018–2025 (USD Million)
Table 161 Asia Pacific: Market, By Application, 2018–2025 (USD Million)
Table 162 Asia Pacific: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 163 Asia Pacific: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 164 Asia Pacific: Synthetic Biology Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 165 Asia Pacific: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 166 Asia Pacific: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 167 Asia Pacific: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 168 Japan: Market, By Tool, 2018–2025 (USD Million)
Table 169 Japan: Market, By Technology, 2018–2025 (USD Million)
Table 170 Japan: Market, By Application, 2018–2025 (USD Million)
Table 171 Japan: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 172 Japan: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 173 Japan: Synthetic Biology Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 174 Japan: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 175 Japan: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 176 Japan: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 177 China: Market, By Tool, 2018–2025 (USD Million)
Table 178 China: Market, By Technology, 2018–2025 (USD Million)
Table 179 China: Market, By Application, 2018–2025 (USD Million)
Table 180 China: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 181 China: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 182 China: Synthetic Biology Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 183 China: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 184 China: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 185 China: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 186 Australia: Market, By Tool, 2018–2025 (USD Million)
Table 187 Australia: Market, By Technology, 2018–2025 (USD Million)
Table 188 Australia: Market, By Application, 2018–2025 (USD Million)
Table 189 Australia: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 190 Australia: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 191 Australia: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 192 Australia: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 193 Australia: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 194 Australia: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 195 India: Market, By Tool, 2018–2025 (USD Million)
Table 196 India: Market, By Technology, 2018–2025 (USD Million)
Table 197 India: Market, By Application, 2018–2025 (USD Million)
Table 198 India: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 199 India: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 200 India: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 201 India: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 202 India: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 203 India: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 204 RoAPAC: Synthetic Biology Market, By Tool, 2018–2025 (USD Million)
Table 205 RoAPAC: Market, By Technology, 2018–2025 (USD Million)
Table 206 RoAPAC: Market, By Application, 2018–2025 (USD Million)
Table 207 RoAPAC: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 208 RoAPAC: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 209 RoAPAC: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 210 RoAPAC: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 211 RoAPAC: Synthetic Biology Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 212 RoAPAC: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 213 Latin America: Market, By Tool, 2018–2025 (USD Million)
Table 214 Latin America: Market, By Technology, 2018–2025 (USD Million)
Table 215 Latin America: Market, By Application, 2018–2025 (USD Million)
Table 216 Latin America: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 217 Latin America: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 218 Latin America: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 219 Latin America: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 220 Latin America: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 221 Latin America: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 222 MEA: Synthetic Biology Market, By Tool, 2018–2025 (USD Million)
Table 223 MEA: Market, By Technology, 2018–2025 (USD Million)
Table 224 MEA: Market, By Application, 2018–2025 (USD Million)
Table 225 MEA: Market for Medical Applications, By Type, 2018–2025 (USD Million)
Table 226 MEA: Market for Drug Discovery & Therapeutics, By Type, 2018–2025 (USD Million)
Table 227 MEA: Market for Artificial Tissue & Tissue Regeneration, By Type, 2018–2025 (USD Million)
Table 228 MEA: Market for Industrial Applications, By Type, 2018–2025 (USD Million)
Table 229 MEA: Market for Industrial Enzymes, By Application, 2018–2025 (USD Million)
Table 230 MEA: Market for Environmental Applications, By Type, 2018–2025 (USD Million)
Table 231 Product Launches, 2017–2019
Table 232 Expansions, 2017–2019
Table 233 Acquisitions, 2017–2019
Table 234 Other Strategies, 2017–2019


List of Figures (38 Figures)

Figure 1 Synthetic Biology Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designations, and Region
Figure 4 Market Size Approach
Figure 5 Bottom-Up Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Tool, 2020 vs. 2025 (USD Million)
Figure 8 Market, By Technology, 2020 vs. 2025 (USD Million)
Figure 9 Market, By Application, 2020 vs. 2025 (USD Million)
Figure 10 Geographic Analysis: Market
Figure 11 Wide Range of Applications of Synthetic Biology Forms the Major Factor Driving Market Growth
Figure 12 Medical Applications Segment Accounted for the Largest Share of the Asia Pacific Market in 2019
Figure 13 China to Witness the Highest Growth During the Forecast Period
Figure 14 North America Will Continue to Dominate the Synthetic Biology Market Till 2025
Figure 15 Developing Markets to Register A Higher Growth Rate in the Forecast Period
Figure 16 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Reduction in Cost Per Raw Megabase of Dna Sequencing (USD) (2009–2019)
Figure 18 Cost of Synthetic Genes (2009–2019)
Figure 19 Funding for Synthetic Biology Companies (2009–2018)
Figure 20 Oligonucleotides & Synthetic Dna Segment to Dominate the Synthetic Biology Tools Market During the Forecast Period
Figure 21 Gene Synthesis Segment to Dominate the Market During the Forecast Period
Figure 22 Market, By Application, 2020 vs. 2025
Figure 23 Market: Geographical Snapshot
Figure 24 North America: Synthetic Biology Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 Asia Pacific: Market Snapshot
Figure 27 Key Growth Strategies Adopted By Market Players From January 2017 to December 2019
Figure 28 Company Share Analysis, By Key Player, 2018
Figure 29 Market: Competitive Leadership Mapping (2019)
Figure 30 Thermo Fisher Scientific, Inc.: Company Snapshot (2018)
Figure 31 Merck Kgaa: Company Snapshot (2018)
Figure 32 Agilent Technologies, Inc.: Company Snapshot (2019)
Figure 33 Novozymes A/S: Company Snapshot (2018)
Figure 34 Amyris, Inc.: Company Snapshot (2018)
Figure 35 Intrexon Corporation: Company Snapshot (2018)
Figure 36 Genscript Biotech Corporation: Company Snapshot (2018)
Figure 37 Codexis, Inc.: Company Snapshot (2018)
Figure 38 Eurofins Scientific: Company Snapshot (2018)

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the synthetic biology market. It was also used to obtain important information about the key players, market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, sales directors, and related key executives from various key companies and organizations operating in the synthetic biology market. Primary sources from the demand side include directors of scientists/researchers from academic & research institutes and government & private laboratories utilizing synthetic biology tools and technologies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Synthetic Biology Market - Attractive Opportunities by 2022

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by tool, technology, application, and region).

Data Triangulation

After arriving at the market size, the synthetic biology market was divided into several segments and subsegments. The data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, wherever applicable.

Objectives of the Study

  • To define, describe, segment, and forecast the global market by tool, technology, application, and region
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players in the global market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as acquisitions, new product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the synthetic biology market
  • To benchmark players within the market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific synthetic biology market into South Korea, New Zealand, and others
  • Further breakdown of the Latin American market into Brazil, Mexico, and Rest of Latin America
Report Code
BT 2910
Published ON
Feb, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Synthetic Biology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home